This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Mark A Peplow: Innovator in Transition Metal Complexes
Introduction
Mark A Peplow is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of chemistry, particularly in the development of new traceless linkers using transition metal complexes. His innovative work has implications for combinatorial chemistry and multiple parallel synthesis.
Latest Patents
Mark A Peplow holds a patent for "Transition metal complexes as linkers." This invention relates to new traceless linkers that utilize transition metal complexes to link a π-orbital containing substrate for subsequent synthesis. This advancement is particularly useful in combinatorial chemistry and multiple parallel synthesis (MPS) applications. He has 1 patent to his name.
Career Highlights
Mark A Peplow is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to further his research and development efforts in innovative chemical solutions.
Collaborations
Throughout his career, Mark has collaborated with talented individuals such as Alex Christian Comely and Sue Elizabeth Gibson. These collaborations have enriched his research and contributed to the advancement of his inventions.
Conclusion
Mark A Peplow is a distinguished inventor whose work in transition metal complexes has paved the way for advancements in combinatorial chemistry. His contributions continue to influence the field and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile